Patient leaflet risk engagement for the MHRA goes to Nesta
- Medicines and Healthcare products Regulatory Agency (MHRA)
- London
- Below threshold - limited competition
- 22 October 2026 to 28 February 2027
The Medicines and Healthcare products Regulatory Agency (MHRA) hired Nesta to talk with less engaged communities about the risk sections of patient information leaflets. Nesta acts as the engagement provider, gathering views on the risk description that the leaflets carry.
The agency chose Nesta through a limited competition and awarded the £79,979 contract in October 2026. The work is due to finish in February 2027.
Contract ends February 2027
- What
- Public consultation, engagement and deliberative processes
- Supplier
- Nesta
- Value
- £79,979
- How it was bought
- Below threshold - limited competition
- Dates and next
- Oct 2026 to Feb 2027